Erin Davis 7/2/26 Erin Davis 7/2/26 Arima Genomics Announces Distribution Partnership with Active Motif for Research-Specific Hi-C Sequencing Kits and Services Read More Erin Davis 6/16/26 Erin Davis 6/16/26 Arima Genomics Named to Fast Company’s 2026 World Changing Ideas List for Aventa Lymphoma Test Read More Erin Davis 6/11/26 Erin Davis 6/11/26 Arima Genomics to Present Data at AMP Europe Showing Hi-C Sequencing Outperforms High-Coverage Whole Genome Sequencing for Lymphoma Rearrangement Detection Read More Erin Davis 5/27/26 Erin Davis 5/27/26 Arima Genomics Announces Presentation of New Data at ASCO 2026 Supporting Clinical Utility of Hi-C Sequencing in Non-Small Cell Lung Cancer Read More Erin Davis 4/15/26 Erin Davis 4/15/26 Arima Genomics Announces AACR 2026 Presentations Across Solid Tumors Read More Erin Davis 2/26/26 Erin Davis 2/26/26 Arima Genomics Announces Publication of New Study Supporting the Whole-Genome Rearrangement Detection Approach Behind Aventa Lymphoma Read More Erin Davis 1/8/26 Erin Davis 1/8/26 Fox Chase Cancer Center and Arima Genomics Partner to Advance 3D Genome Diagnostics for Cancer Care Read More Erin Davis 12/4/25 Erin Davis 12/4/25 Arima Genomics Reports New Data at ASH 2025 Supporting More Complete Rearrangement Profiling in DLBCL With Hi-C Technology Used in Aventa Lymphoma Read More Erin Davis 11/13/25 Erin Davis 11/13/25 Arima Genomics Announces Data Presentation at the Association of Molecular Pathology 2025 Read More Erin Davis 11/6/25 Erin Davis 11/6/25 Arima Genomics Wins BioTech Breakthrough Award For “Clinical Diagnostics Solution of the Year” Read More Erin Davis 10/15/25 Erin Davis 10/15/25 Arima Genomics Announces New Study Showing Aventa™ Lymphoma Test Resolves Diagnostic Ambiguity and Guides Care in B-Cell Lymphoma Cases Read More Erin Davis 9/3/25 Erin Davis 9/3/25 Arima Genomics Introduces Aventa Lymphoma Test to Resolve Diagnostic Uncertainty in B- and T-Cell Lymphomas Read More Erin Davis 6/17/25 Erin Davis 6/17/25 Arima Genomics Appoints Genomics Industry Veteran Tom Willis as Chief Executive Officer and Closes $22 Million Series C Financing Read More Erin Davis 4/10/25 Erin Davis 4/10/25 New Study Shows Arima Genomics’ Technology Detects Actionable Cancer Drivers in Solid Tumors Missed by Standard Tests Read More
Erin Davis 7/2/26 Erin Davis 7/2/26 Arima Genomics Announces Distribution Partnership with Active Motif for Research-Specific Hi-C Sequencing Kits and Services Read More
Erin Davis 6/16/26 Erin Davis 6/16/26 Arima Genomics Named to Fast Company’s 2026 World Changing Ideas List for Aventa Lymphoma Test Read More
Erin Davis 6/11/26 Erin Davis 6/11/26 Arima Genomics to Present Data at AMP Europe Showing Hi-C Sequencing Outperforms High-Coverage Whole Genome Sequencing for Lymphoma Rearrangement Detection Read More
Erin Davis 5/27/26 Erin Davis 5/27/26 Arima Genomics Announces Presentation of New Data at ASCO 2026 Supporting Clinical Utility of Hi-C Sequencing in Non-Small Cell Lung Cancer Read More
Erin Davis 4/15/26 Erin Davis 4/15/26 Arima Genomics Announces AACR 2026 Presentations Across Solid Tumors Read More
Erin Davis 2/26/26 Erin Davis 2/26/26 Arima Genomics Announces Publication of New Study Supporting the Whole-Genome Rearrangement Detection Approach Behind Aventa Lymphoma Read More
Erin Davis 1/8/26 Erin Davis 1/8/26 Fox Chase Cancer Center and Arima Genomics Partner to Advance 3D Genome Diagnostics for Cancer Care Read More
Erin Davis 12/4/25 Erin Davis 12/4/25 Arima Genomics Reports New Data at ASH 2025 Supporting More Complete Rearrangement Profiling in DLBCL With Hi-C Technology Used in Aventa Lymphoma Read More
Erin Davis 11/13/25 Erin Davis 11/13/25 Arima Genomics Announces Data Presentation at the Association of Molecular Pathology 2025 Read More
Erin Davis 11/6/25 Erin Davis 11/6/25 Arima Genomics Wins BioTech Breakthrough Award For “Clinical Diagnostics Solution of the Year” Read More
Erin Davis 10/15/25 Erin Davis 10/15/25 Arima Genomics Announces New Study Showing Aventa™ Lymphoma Test Resolves Diagnostic Ambiguity and Guides Care in B-Cell Lymphoma Cases Read More
Erin Davis 9/3/25 Erin Davis 9/3/25 Arima Genomics Introduces Aventa Lymphoma Test to Resolve Diagnostic Uncertainty in B- and T-Cell Lymphomas Read More
Erin Davis 6/17/25 Erin Davis 6/17/25 Arima Genomics Appoints Genomics Industry Veteran Tom Willis as Chief Executive Officer and Closes $22 Million Series C Financing Read More
Erin Davis 4/10/25 Erin Davis 4/10/25 New Study Shows Arima Genomics’ Technology Detects Actionable Cancer Drivers in Solid Tumors Missed by Standard Tests Read More
